Proteins
Recombinant Human DDAH1
- Cat.4001
- SpeciesHuman
- SourceE. coli
Purity and activity of rhDDAH1-GST: SDS-PAGE (left) and ADMA-hydrolysis activity (right), from the product datasheet. Lot-specific values are provided on the COA.
Product details
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 — an E. coli-expressed, activity-tested enzyme that hydrolyzes ADMA, for nitric-oxide and vascular research.
| Catalog Number: | 4001 |
|---|---|
| Species: | Human |
| Source: | E. coli |
| Amino acids: | 2–285 |
| Protein ID: | O94760 (DDAH1_HUMAN) |
| Predicted molecular weight: | 58.1 kDa (with GST tag) |
| SDS-PAGE molecular weight: | 58 kDa |
| Purity: | >85% by SDS-PAGE (SimplyBlue SafeStain) |
| Functional activity: | >50 pmol/min/µg (ADMA-hydrolysis assay) |
| Endotoxin: | <1 EU/µg (LAL method) |
| Formulation: | 0.5 mg/mL in 50 mM Tris-HCl pH 8.0, 20 mM reduced glutathione, 1 mM DTT; frozen |
| Storage & stability: | −80 °C in aliquots; 12-month stability. Avoid repeated freeze-thaw. |
| Intended use: | For research use only. Not for use in diagnostic or therapeutic procedures. |
Functional activity
Activity-tested at >50 pmol/min/µg in an ADMA-hydrolysis assay. DDAH1 degrades asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric-oxide synthase — supporting studies of vascular function and angiogenesis. Lot-specific activity is provided on the COA.
Scientific background
DDAH1 (dimethylarginine dimethylaminohydrolase 1) hydrolyzes ADMA and N(G)-monomethyl-L-arginine, methylarginines that inhibit nitric-oxide synthase. By clearing ADMA, DDAH1 activity influences nitric-oxide availability, vascular tone and angiogenesis, making it a target of interest in cardiovascular and endothelial research.
Publications using DAPCEL technology and products are listed on the publications page.
Published studies that used this product
All publicationsMore proteins
See all